Insider · CIK 0001656998
Robert Azelby
director
Files at CAH (CARDINAL HEALTH INC), ADCT (ADC Therapeutics SA), TERN (Terns Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | ADCT ADC Therapeutics SA | FTax withholding Common Shares | -12,600 | $3.58 | $45k | 80,405 | Jun 17, 2025 |
| Jun 3, 2025 | ADCT ADC Therapeutics SA | AGrant or award Common Shares | +40,000 | $0.00 | $0 | 93,005 | Jun 5, 2025 |
| Feb 20, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Feb 24, 2025 |
| Nov 6, 2024 | CAH CARDINAL HEALTH INC | AGrant or award Common Shares | +1,730 | $0.00 | $0 | 3,018 | Nov 7, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.